HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Mindfulness meditation improved quality of life in adolescents with cancer

Christine A. Zawistowski, MD

Case Challenges

A 54-year-old woman with bilateral hydronephrosis

Ramya Varadarajan, MD

Cover Stories

Growth of 340B program triggers ‘battle over big money’


Cancer trials: Lies, damned lies and statistics

Derek Raghavan, MD, PhD

FDA approvals

FDA approves Zydelig for CLL, SLL, follicular lymphoma

In the Journals

Recurrent VTE linked to certain cancers, leg paresis

Sarcopenia increased risk for mortality after radical cystectomy for bladder cancer

Shift in NSCLC trial design, interpretation linked to inefficiency

Letermovir reduced cytomegalovirus infection after HSCT

Modafinil no different than placebo for fatigue reduction in NSCLC

30% of breast cancer survivors unemployed 4 years after treatment

Multifaceted intervention improved colorectal cancer screening adherence

PET/CT predicted outcomes in primary mediastinal large B-cell lymphoma

Patients with HIV, cancer less likely to receive oncology treatment

Classifier preoperatively identified medullary thyroid cancer

Double mastectomy decreased mortality among women with BRCA mutations

Catheter-directed thrombolysis did not benefit, may harm patients with DVT

Two mutations linked to success of adoptive T-cell therapy in melanoma

Addition of oxaliplatin to folinic acid-modulated fluorouracil extended survival in pancreatic cancer

MRD may guide augmented post-remission treatment in pediatric ALL

HPV status predicted OS after progression in oropharyngeal cancer

<em>H. pylori</em> eradication failed to reduce risk for gastric cancer after resection

Institution Notes

Rutgers director receives award

ASTRO announces 2014 fellows class

St. Jude researcher receives ASCO award

City of Hope appoints new board of directors chair

Melanoma researcher joins cancer institute